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INTRODUCTION
Dementia is a leading cause of years of life lost due to disability and a major public health challenge for the twenty-first century (Murray et al., 2012 , Sloane et al., 2002 . Among the strategies to reduce the global burden of dementia, prevention currently has greater potential than cure, and certainly greater value than current symptomatic treatments. Potentially modifiable risk factors for Alzheimer's disease (AD), the most frequent cause of dementia, include diabetes mellitus, midlife hypertension or obesity, physical inactivity, smoking, limited education and depression (Norton et al., 2014) . If depression is causally linked to AD, it may account for 8% of all cases of AD worldwide, indicating that nearly 1 in every 10 cases of AD could be averted or deferred if depression were successfully treated or prevented (Norton et al., 2014) .
Although there is no proof, by means of randomized controlled trials, that preventing or treating depression reduces the incidence of dementia, a systematic review and meta-analysis of 23 cohort studies reported that depression after age 50 years was associated with an increased odds of allcause dementia [odds ratio (OR) and 95% confidence interval (95%CI), OR=1.85, 95%CI=1.67-2.04)], AD (OR=1.65, 95%CI=1.42-1.92) and vascular dementia (VD) (OR=2.52, 95%CI=1.77-3.59) (Diniz et al., 2013) . Whilst these results are consistent with the hypothesis that depression causes dementia, the diagnosis of depression in most studies relied on the use of depression scales rather than validated diagnostic criteria, confounding could potentially explain the findings (i.e., common risk factors associated with both depression and dementia), and the time-gap between exposure to depression and onset of dementia varied widely (1 to 17 years). Hence, depressive symptoms could simply herald the early stages of an ongoing dementia process rather than being the cause of it. Indeed, only 2 of the 23 studies included in the meta-analysis provided follow up data for periods longer than 9 years (Diniz et al., 2013) .
We aimed to circumvent this uncertainty by investigating if both early and late-life depression are associated with the development of cognitive impairment in a community representative sample of older Western Australian men (Norman et al., 2009) . We hypothesized that both past and current depression would increase the risk of incident cognitive impairment amongst participants.
METHODS

Study design and setting
This is a cohort study of a community-derived sample of older men living in the Perth metropolitan region of Western Australia.
Participants
The sample consisted of 4568 men aged 70-89 years who completed the second wave of assessments of the Health In Men Study (HIMS) in 2001-2004. Briefly, HIMS is an ongoing cohort study of a random community sample of 12,203 older men recruited between 1996-1998 for a study of abdominal aortic aneurysm. An additional third wave of clinical assessments took place in 2008.
Details about the study design and cohort have been described elsewhere (Almeida et al., 2014 , Norman et al., 2009 . Eligible men had Mini-Mental State Examination (MMSE) scores ≥ 24 (Crum et al., 1993) (Holman et al., 2008 , Holman et al., 1999 .
The recorded diagnoses follow the International Classification of Diseases (ICD) coding system of the 9 th edition until 30/06/2008 and 10 th edition thereafter. The following codes indicated the presence of dementia: 290.x, 294.1 and 294.2 (ICD-9), and F00, F01, F02 and F03 (ICD-10).
This study followed the principles of the Declaration of Helsinki and was approved by the Ethics
Committees of the University of Western Australia and of the Department of Health of Western
Australia. Participants provided written informed consent to participate.
Healthy participant bias
Men who consented to join HIMS were healthier than other eligible men living in the community (Almeida et al., 2014) , and those who completed the second assessment had less comorbidities than their surviving counterparts lost throughout the follow up period (Almeida et al., 2014 , Almeida et al., 2008a .
Explanatory variables
The principal explanatory variable of the study was the presence of past or current depression at the start of the follow up period. We used three complementary strategies to identify men with past depression: (i) recorded diagnosis of a depressive episode in WADLS before the date of assessment (ICD-9 codes 296.2, 296.3, 296.82, 296.90, 298.0 and 311, and ICD-10 codes F32, F33, F34.1 and F38.10), (ii) response in the affirmative to the question 'Have you ever had treatment for an emotional or nervous illness such as depression?', or (iii) use of an antidepressant at the time of assessment. We judged that participants showed evidence of current clinically significant symptoms of depression if they scored 7 or more on the 15-item version of the Geriatric Depression Scale (GDS-15) at the time of assessment (Almeida and Almeida, 1999) . All other men were considered to have not experienced a clinically significant episode of depression.
At the start of the follow up period participants completed a health questionnaire that collected information about their age (in years), place of birth (Australia or other), educational attainment (incomplete vs complete high school education), and smoking (never, past or current). In addition, we considered that participants had hypertension if their systolic blood pressure was ≥140 mmHg or their diastolic blood pressure was ≥ 90 mmHg, or if they reported having been advised by their doctor that they had hypertension. The presence of diabetes was ascertained by asking participants if a doctor had ever told them that they had diabetes or if they reported treatment to lower blood sugar. Similarly, men indicated whether a doctor had ever told them that they had had a stroke, or a heart attack or angina (which we considered indicative of the presence of coronary heart disease).
Follow-up
We invited participants to complete an additional assessment with the Telephone Interview for Cognitive Status modified (TICS) during 2008 and used this information to assign men to three groups: normal cognitive function (TICS > 31), mild cognitive impairment (MCI; 27< TICS ≤ 31) and cognitive impairment (TICS ≤ 27) (Knopman et al., 2010) . These cut-points have been associated with sensitivity and specificity of 71% and 78% to separate MCI from normal cognitive function, and 69% and 71% to separate MCI from dementia (Knopman et al., 2010) . In addition, we identified participants who did not return for assessment but received a WADLS diagnosis of dementia between the 2001-4 and the 31st December 2008. These men were assigned to the 'cognitive impairment' group. Finally, we used the WADLS to identify men who died between the date of enrolment and the 31st December 2008.
Outcomes
The primary outcome was incident cognitive impairment and mild cognitive impairment by the 31st 
Statistical methods
Data were managed and analysed with the statistical package Stata/IC 13.1 (StataCorp LP, 2014).
We used descriptive statistics to summarise categorical data as count and proportions (%), and continuous variables as mean, range, and standard deviation of the mean (SD). We used the Pearson chi-square statistic (X 2 ) to determine the probability that the distribution of exposures among people with past, current and no history of depression could be attributed to chance, and reported the number of degrees of freedom (df) and the probability (p-value) of the associations having arisen as a result of chance. We employed multinomial logistic regression to calculate the risk rate ratio (RR) and respective 95% confidence interval (95%CI) of MCI, cognitive impairment, death and unavailability for the follow up cognitive assessment in 2008 according to depression history and other explanatory variables. The RR of the clinical outcomes was later adjusted for other measured factors. Alpha was set at 0.05 and all tests reported are two-tailed.
RESULTS
The mean±SD age of the 4568 men who took part in this study was 77.1±3.6 years. Of these, 253 (5.5%) had clinically significant depressive symptoms at the time of assessment, with another 527 (11.5%) showing evidence of past depression. Table 1 summarises the baseline sociodemographic and clinical characteristics of participants according to their history of depression. Men with clinical significant depressive symptoms at baseline were older and more likely to be born outside Australia, poorly educated, smokers, diabetic with a history of coronary heart disease or stroke. In addition, of the 527 men assigned to the 'past depression' group, 227 (43.1%) were using an antidepressant. Forty-one (16.2%) of the 253 participants with GDS-15≥7 were also using an antidepressant. (mean±SD follow up time = 5.2±0.8 years). The risk of MCI, cognitive impairment, death and unavailability for the follow up assessment increased with increasing age and was particularly high for those older than 80 years. The RR of non-availability for follow up was higher among participants not born in Australia (OR=1.25; 95%CI=1.06-1.45), whereas the odds ratio of MCI, cognitive impairment, death and unavailability was lower for men with complete compared with incomplete high school education. Diabetes increased the RR of cognitive impairment, death and unavailability, but not of MCI. The RR of death also increased with history of current smoking, diabetes, coronary heart disease and stroke. Similarly, unavailability was more frequent among current smokers and men with clinical history of diabetes and stroke (Table 2) .
TABLE 2
History of past depression did not increase the RR of MCI or cognitive impairment, but current depression did increase the RR of future cognitive impairment (RR=2.59, 95%CI=1.57-4.27;
RR=2.07, 95%CI=1.24-3.45 after adjustment for other measured factors). Past and current depression at the beginning of follow up were associated with increased risk of death, whereas current depression was also associated with unavailability at the follow up assessment (Table 3) .
We repeated these analyses after the exclusion of men who were using an antidepressant at the time of entry into the study: the results remained largely unchanged (Table 3) .
Post hoc analyses showed that there was no obvious 'dose effect' of depression severity on the future development of cognitive impairment: compared with participants who scored < 5 on the GDS-15 (i.e., no depression), the crude RR of cognitive impairment was 2.11 (95%CI=1.40-3.18) for men with GDS-15 scores between 5 and 9 (mild to moderate depression) and 2.70 (95%CI=1.16-6.28) for those with GDS-15 ≥ 10 (severe depression). After statistical adjustment for age group, country of birth, education, smoking history, and prevalence hypertension, diabetes, coronary heart disease and stroke, the respective RR of cognitive impairment were 1.83 (95%CI=1.21-2.79) and 2.24 (95%CI=0.95-5.31). 
DISCUSSION
The results of this study showed that history of past depression was not associated with the risk of incident cognitive impairment (either mild or major cognitive impairment) in older men. In contrast, evidence of clinically significant symptoms of depression at the start of the follow up period more than doubled the risk of cognitive impairment over the subsequent 5 years, although it had no effect on the risk of mild cognitive impairment. These findings were independent of other measured factors, as well as of death and loss to follow up. As MCI represents an intermediate evolutionary state between normality and overt cognitive impairment (Petersen et al., 2014) , the lack of association between current depression and future MCI, as well as the lack of association between past depression and cognitive impairment, suggests (but does not prove) that the link between depression and cognitive impairment is not causal.
Strengths and limitations
Before discussing the implications of our findings, we will consider the limitations of our study design and how these, chiefly potential for bias and confounding, may have influenced the results.
Participants were derived from a large community-representative sample of older men for whom a wealth of questionnaire and health service use data was available (Norman et al., 2009 , Prina et al., 2013 . Men who completed the 2001-2004 wave of assessments for HIMS were healthier than those who were still alive but were not available (Almeida et al., 2014 , Almeida et al., 2008b . The implication of such healthy participant bias is that fewer men with depression would have joined this survey, leading to a loss of power to detect future associations with depression (type II error).
We are confident that by using the MMSE and WADLS we excluded from the analyses prevalent cases of cognitive impairment, but we are less certain that all past depressive episodes would have been identified correctly by means of self-report and WADLS. As WADLS only retrieves data from public outpatient and hospital services, less severe cases of depression managed in the private sector or at primary care level would not have been recorded (Holman et al., 2008 , Holman et al., 1999 .
Although self-report would have contributed to mitigate this type of bias, the accuracy and completeness of the approach we used to ascertain past depression is yet to be tested. In addition, the sensitivity of WADLS in identifying people with dementia is low (Zilkens et al., 2009) , so that potential cases of cognitive impairment may have gone unidentified amongst those who died or were not available for the cognitive assessment. If that were the case, then the number of people with cognitive impairment could have been larger, and this would have increased the power of the study to identify associations with depression. Notwithstanding such a caveat, our study had sufficient power to declare as significant risk rates of the order of 1.5, which suggests that this potential misclassification of cases of cognitive impairment would have had limited bearing on the clinical significance of the findings.
Despite prospective follow-up of all participants, 30% of them did not complete the cognitive assessment and 18% died during the 5-year follow up. If men with history of past depression who are at greater risk of developing cognitive impairment died early, then survivorship bias could potentially account for the lack of association between past depression and cognitive impairment.
Although we are unable to dismiss this possibility, this would seem unlikely to explain our results, as the effect size of the observed association between past depression and cognitive impairment was negligible (i.e., nearly all cases who died would have had to have experienced past depression and developed cognitive impairment for the effect to become statistically significant), and the effect was not modified by the exclusion from the sample of men using antidepressants. Nonetheless, we concede that if a large proportion of men with past depression were misclassified as non-cases (i.e., false negatives), this would have led to a loss of power to investigate the association with future cognitive impairment.
It may also seem surprising that stroke was not associated with cognitive impairment at follow up.
Severe and more disabling strokes are commonly associated with significant disability and mortality (which is consistent with the increased risk of death and unavailability in our sample), so that survivors are often at the more benign end of disease spectrum. Moreover, our study was not powered to investigate the association between stroke and cognitive impairment, as most men (60%) with past history of stroke either died or were unavailable for follow up.
If, in at least some instances, depression is a prodromal expression of dementia in older age, then a follow up period of 5 years should have been sufficiently long for the clinical manifestations of dementia to become apparent (Amieva et al., 2008) . In contrast, if depression is a true risk factor for dementia, then more prolonged follow up could have yielded more cases. Our study collected information about past depression (i.e., more than 5 years before the onset of cognitive impairment) and found no evidence of such a link. We acknowledge, however, that we did not have access to information about the age of onset of depression, the number of past episodes, or the type and duration of antidepressant treatments used. Hence, we were unable to determine if any of these factors could have potentially modified the association between depression and incident cognitive impairment. Furthermore, we acknowledge that, like other surveys, our definition of 'current depression' relied on the use of a depression rating scale rather than a structured clinical interview leading to a diagnosis of major depression according to accepted criteria.
There is also the potential issue of confounding associated with unmeasured factors, such as socioeconomic status, physical activity, and access to health services. It is conceivable that such factors could explain some of the association between current depression and future cognitive impairment (Lautenschlager et al., 2008) , although it seems improbable that they could explain all of it, particularly because our statistical adjustments for other measured factors did not have a pronounced effect on the results.
Finally, we acknowledge that the use of multinomial logistic regression does not take into account time to event, which could not be accurately assessed in this survey, and that, as our data are restricted to older men, we cannot be certain that the same findings would be observed in women.
Interpretation of the results
We designed this study to determine if depression is causally related to the development of cognitive impairment in later life. Taken together, our results seem to have answered this question in the negative. Past studies have identified depression as a risk factor for cognitive impairment, although most have been limited to late-life depression (Diniz et al., 2013) . Li and colleagues examined data from 3410 adults aged 65 years who were followed for 7 years as part of the Adults Changes in Thought Study (Li et al., 2011) . They used the Center for Epidemiologic Studies Depression Scale (CES-D-11) to assess depressive symptoms and considered a score of 11 or greater indicative of clinically significant symptoms. Participants self-reported history of past depression and the diagnosis of dementia followed clinical assessment and DSM-IV criteria. The hazard ratio (HR) of dementia associated with baseline depression was 1.7 (95%CI=1.4-2.1), although clinically significant depression with onset before age 50 years did not increase dementia hazard (HR=1.1, 95%CI=0.8-1.5). The authors concluded that some cases of late life depression represent a prodromal manifestation of dementia and that depression per se does not increase dementia risk (Li et al., 2011) . Similar findings have since been reported by others (Vilalta-Franch et al., 2013) , and are consistent with our own. Compared with the Adults Changes in Thought Study, HIMS has the merit of having had access to the Western Australia Data Linkage System to optimise the identification of cases of past depression as well as of dementia.
We also investigated the effect of severity of symptoms in order to clarify if the association between prevalent depression and incident cognitive impairment was subject to a dose-effect that could be supportive of a causal link: we found no compelling evidence of such a link. Others have reported some evidence for a dose-effect with every 10-points increase in CES-D scores (Saczynski et al., 2010) , although the HR of dementia reported was averaged (HR=1.5, 95%CI=1.2-1.8) and
the reference group had no depression (i.e., CES-D ≤ 10). In other words, these results may have simply reflected the average effect of having depression compared with no depression.
It is conceivable that our results could reflect the fact that depression with onset in early and late life have distinct pathogeneses. The 'vascular depression' hypothesis implies that depression with late onset is commonly due to cerebrovascular disease (Alexopoulos et al., 1997) , which could diminish brain reserve and bring forward the onset of dementia (Snowdon et al., 1997) . Empirical evidence in support of the vascular hypothesis of late life depression is not compelling (Almeida, 2008) , but it highlights the fact that some older adults who display clinically significant symptoms of depression in later life carry greater disease burden in their brains than those who do not (Kohler et al., 2010) . In this case, depressive symptoms (not necessarily a major depressive episode) would represent a clinical manifestation of the underlying brain abnormalities that also lead to cognitive impairment (Korten et al., 2014) .
In summary, the results of our study are consistent with the hypothesis that depression in later life is a prodromal manifestation of cognitive impairment rather than the cause of it. If future studies prove this to be true, the successful treatment or prevention of depression in early life would not be expected to affect the prevalence of cognitive impairment in later life. Instead, depression in older age might identify a group of people who may benefit from interventions designed to delay progression to cognitive impairment over time, in the same way as MCI. .34 (1.13-1.59 .66 (1.26-2.19)  1.67 (1.25-2 
